Authors
Latest:
Case Report: Repigmentation of the Lips Using RuxolitinibDive into a complex case report of a 29-year-old African American male patient with Fitzpatrick skin type V with a 6-month reported history of vitiligo on his lips.
Latest:
Key Takeaways for the Management of Plaque PsoriasisExperts in dermatology share final thoughts on the treatment of plaque psoriasis and the ever-changing treatment landscape.
Latest:
Cutiss, DenovoSkin Changing the Standard of Burn Care Across the GlobeCEO Daniela Marino, PhD, emphasizes that the Switzlerand based company has received Orphan Drug Designation from the Swissmedic, EMA, and FDA, for its personalized human skin graft.
Latest:
Upadacitinib Demonstrates Efficacy in Patients With AD and Head and Neck InvolvementKilian Eyerich, MD, PhD, shares insights into an EADV 2024 presentation on upadacitinib’s ability to achieve almost total skin clearance in the head and neck regions with minimal effect on quality of life.
Latest:
Additional Medicaid Expansion Would Provide Advantages to Patients With MelanomaDuring the 2024 American Society of Clinical Oncology annual meeting, a poster highlighted the advantages Medicaid expansion could offer to individuals with melanoma.
Latest:
Frontline Forum Part 3: Challenges and Opportunities to Enhance Psoriasis ManagementA panel of experts discusses tailoring treatment to patient needs, supporting patients' mental health, and considering future directions.
Latest:
Dermatology Times in France: What La Roche-Posay Products Dermatologists Recommend for Eczema, AcneDermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.
Latest:
Mohs for the Nose: Reconstruction Session Sneak Peek With Anna Bar, MD, FACMSBar will share insight on foldover interpolated flaps for full thickness of nasal defects.
Latest:
New, Difficult-to-Treat Fungal Skin Infections Are Emerging, Clinicians WarnTwo new forms of Trichophyton mentagrophytes type VII and Trichophyton indotineae are emerging, according to a new report.
Latest:
Jeremy Brauer, MD, Publishes Men’s Aesthetics TextbookBrauer’s textbook can be purchased through Amazon and Barnes & Noble.
Latest:
Can Supplements Effectively Manage Hair Loss?Data presented at the American Academy of Dermatology 2022 Annual Meeting shows what supplements can and cannot manage alopecia areata.
Latest:
Assessing Quality of Life and AAD Research ConsiderationsAlan Irvine, MD, DSc, shares insights on the impact of ruxolitinib on quality of life in pediatric patients and 2024 AAD research presentations to take into consideration.
Latest:
Insights Into Positive Decision for Galderma's RelabotulinumtoxinA in EuropeSachin Shridharani, MD, FACS, discusses the READY-1 and READY-2 clinical trials and positive support for Relfydess.
Latest:
Striving for Melanoma Advancements With the Melanoma Research AllianceMarc Hurlbert, PhD, discusses how the Melanoma Research Alliance works with dermatology clinicians to provide fundings and resources for melanoma research.
Latest:
Discussion of Traditional and Novel GPP Treatment ModalitiesAn expert in dermatology shares his insights into the management considerations with traditionally utilized treatments for generalized pustular psoriasis and discusses the impact of a recent approval in this space.
Latest:
What You Need to Know About Mentoring DoctorsDefining the goals of the mentoring relationship can be useful to clarify expectations.
Latest:
Best Communication Practices to Explain Palliative Care PlansKatie Schlenker, DO, emphasizes the importance of empathy during tough conversations with skin cancer patients with few to no treatment options left.
Latest:
Clascoterone cream 1% targets androgen receptorsThe topical cream is the first acne drug with a new mechanism of action to win FDA approval in the last 40 years.
Latest:
Tracee Blackburn, PA-C: Gut Health for Healthy SkinBlackburn presented integrative medicine pearls on gut and hormone health at the 2024 Diversity in Dermatology meeting.
Latest:
Alternative Care Options for Inflammatory DiseasesConsidering the whole patient is crucial in understanding how natural alternatives can improve the skin.
Latest:
Rocco Serrao, MD Looks Ahead to Bimekizumab’s ApprovalWe had the chance to catch up with Serrao before he took the stage and he explained why dermatology clinicians should keep their eyes on bimekizumab’s data and shared opportunities for further research.
Latest:
LEAP-010 Study Discontinued for Patients with PD-L1-Expressing HNSCCA coprimary end point in the phase 3 LEAP-010 study will not be met.
Latest:
Retinoic Acid, Vitamin A Demonstrates Role in Regulating Hair Follicles and Epidermal Stem CellsIn vitro studies demonstrated that retinoic acid aids stem cells in transitioning away from a state of flexibility in wound healing.
Latest:
Looking Ahead to the 2023 ACMS MeetingThe ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.
Latest:
‘Next-Generation TYK2 Inhibitor’: Insights into ZasocitinibChristopher Bunick, MD, PhD, shared insights into zasocitinib’s presented data and ongoing clinical trials.
